The intrapituitary stimulatory effect of lipopolysaccharide on ACTH secretion is mediated by paracrine-acting IL-6

Summary:

During infection/inflammation bacterial lipopolysaccharide (LPS) activates the immune system and thus enhances the level of circulating cytokines. These circulating cytokines induce adaptive processes within the endocrine system and in particular stimulate the HPA axis to increase the level of anti-inflammatory-acting glucocorticoids in the circulation. We have shown recently that LPS stimulates intrapituitary IL-6 production in folliculostellate cells via specific receptors and the p38a mitogen-activated protein kinase/nuclear factor-kappa B pathway. To test the physiological relevance of these findings, we studied whether LPS could enhance ACTH secretion via paracrine-acting intrapituitary IL-6. Lipopolysaccharide stimulated IL-6 secretion both in monolayer and aggregate mouse pituitary cell cultures, but only in aggregates, ACTH secretion was significantly enhanced by LPS. Other hormones, such as GH or PRL, were less stimulated by LPS. My4, an antibody that blocks the interaction of LPS with the LPS receptor CD14, suppressed both LPS-induced IL-6 and ACTH secretion in aggregate cultures. A neutralizing antibody against mouse IL-6 also inhibited LPS-induced ACTH secretion in aggregates. In mouse pituitary fragments, LPS-induced ACTH secretion was blocked by My4 and IL-6 antibodies, identically to re-aggregate cell cultures. LPS-induced ACTH secretion, mediated by intrapituitary IL-6, may represent a pituitary-specific mechanism that stimulates the HPA axis during infection/inflammation.

Key words:

Anterior pituitary - folliculostellate cell - lipopolysaccharide - interleukin-6 - ACTH

References

• 1 Arzt E. et al. . Pathophysiological role of the cytokine network in the anterior pituitary gland.  Front Neuroendocrinol. 20 71-95 1999; 
• 2 Arzt E. et al. . Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 (IL-2) and IL-6.  Endocrinology. 132 459-467 1993; 
• 3 Benter S. et al. . Paracrine cell to cell interactions determine the effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vitro prolactin release from rat pituitary cells.  Exp Clin Endocrinol Diabetes. 103 386-390 1995; 
• 4 Besedovsky H O, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses.  Endocr Rev. 17 64-102 1996; 
• 5 Chrousos G P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.  New Engl J Med. 332 1351-1362 1995; 
• 6 Golenbock D T, Bach R R, Lichenstein H, Juan T S-C, Tadavarthy A, Moldow C F. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.  J Lab Clin Med. 125 662-671 1995; 
• 7 Hailman E. et al. . Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.  J Exp Med. 179 269-277 1994; 
• 8 Inoue K. et al. . Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor.  Endocrinology. 131 3110-3116 1992; 
• 9 Kobayashi H. et al. . Tumor necrosis factor receptors in pituitary cells.  Brain Res. 758 45-50 1997; 
• 10 Kreutz M. et al. . A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphylococcus aureus in human monocytes.  Immunology. 92 396-401 1997; 
• 11 Lohrer P. et al. . Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38a mitogen-activated protein kinase/nuclear factor-κB pathway.  Endocrinology. 141 4457-4465 2000; 
• 12 Loppnow H, Stelter F, Schönbeck U, Schlüter C, Ernst M, Schütt C, Flad H-D. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.  Infect Immun. 63 1020-1026 1995; 
• 13 Matsumoto H, Koyama C, Sawada T, Koike K, Hirota K, Miyake A, Arimura A, Inoue K. Pituitary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotrophic peptide (pituitary adenylate cyclase-activating peptide), showing increased adenosine 3′, 5′-monophosphate and interleukin-6 secretion and cell proliferation.  Endocrinology. 133 2150-2155 1993; 
• 14 Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen.  Endocrinology. 133 2574-2578 1993; 
• 15 Ohmichi M, Hirota K, Koike K, Kurachi K, Ohtsuka S, Matsusaki N, Yamaguchi M, Miyake A, Tanizawa O. Binding sites for interleukin-6 in the anterior pituitary gland.  Neuroendocrinology. 55 199-203 1992; 
• 16 Ozawa H, Ito T, Ochiai I, Kawata M. Cellular localization and distribution of glucocorticoid receptor immunoreactivity and the expression of glucocorticoid receptor mRNA in rat pituitary gland. A combined double immunohistochemistry study and in situ hybridization histochemical analysis.  Cell Tissue Res. 295 207-214 1999; 
• 17 Paez Pereda M, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervin A, Berner S, Molina H, Stalla G K, Renner U, Arzt E. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.  Exp Clin Endocrinol Diabetes. 108 202-207 2000; 
• 18 Poltorak A, He X, Smirnova I, Liu M Y, Huffel C V, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in the Tlr4 gene.  Science. 282 2085-2088 1998; 
• 19 Renner U, Pagotto U, Arzt E, Stalla G K. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review.  Eur J Endocrinol. 135 515-532 1996; 
• 20 Renner U, Newton C J, Pagotto U, Sauer J, Arzt E, Stalla G K. Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation.  Endocrinology. 136 3186-3193 1995; 
• 21 Renner U, Gloddek J, Arzt E, Inoue K, Stalla G K. Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells.  Exp Clin Endocrinol Diabetes. 105 345-352 1997; 
• 22 Schwartz J. Intercellular communication in the anterior pituitary.  Endocr Rev. 21 488-513 2000; 
• 23 Spangelo B L, Gorospe W C. Role of the cytokines in the neuroendocrine-immune system axis.  Front Neuroendocrinol. 16 1-22 1995; 
• 24 Spangelo B L, Judd A M, Isakson P C, MacLeod R M. Interleukin-1 stimulates interleukin-6 release from rat anterior pituitary cells in vitro.  Endocrinology. 128 2685-2692 1991; 
• 25 Spangelo B L, Isakson P C, MacLeod R M. Production of interleukin-6 by anterior pituitary cells is stimulated by increased intracellular adenosine 3′,5′-monophosphate and vasoactive intestinal peptide.  Endocrinology. 127 403-409 1990; 
• 26 Tatsuno I, Somogyvari-vigh A, Mizuno K, Gottschall P E, Hidaka H, Arimura A. Neuropeptide regulation of interleukin 6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.  Endocrinology. 129 1797-1804 1991; 
• 27 Tilders F JH, DeRijk R H, van Dam A-M, Vincent V AM, Schotanus K, Persoons J HA. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals.  Psychoendoneurocrinology. 19 209-232 1994; 
• 28 Ulevitch R J, Tobias P S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.  Annu Rev Immunol. 13 437-457 1995; 
• 29 van Deventer S JH, Buller H R, ten Cate J W, Aarden L A, Hack C E, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.  Blood. 76 2520-2526 1990; 
• 30 Vankelecom H, Carmeliet P, Van Damme J, Billiau A, Denef C. Production of Interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system.  Neuroendocrinology. 49 102-106 1989; 
• 31 Vankelecom H, Matthys P, Van Damme J, Heremans H, Billiau A, Denef C. Immunocytochemical evidence that S-100 positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity.  J Histochem Cytochem. 41 151-156 1993;